Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $85.75M.
ENTERPRISE VALUE (EV)
$85.75M
Precision BioSciences, Inc.
Market Cap
$174.17M
Enterprise Value (EV)
$85.75M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Precision BioSciences, Inc. (DTIL) | $174.17M | $85.75M |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | $127.82M |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | $147.17M |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | $168.38M |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | $142.45M |
| Journey Medical Corporation (DERM)vs › | $184.12M | $184.02M |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | $149.84M |
| Inogen, Inc. (INGN)vs › | $160.82M | $89.34M |
| LifeMD, Inc. (LFMDP)vs › | $155.88M | $136.75M |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | $186.63M |
Market Cap
$174.17M
Total Debt
$22.40M
Cash
$110.82M
Enterprise Value
$85.75M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
